About 2 400 reports

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Healthcare
  • Infectious Disease
  • Genetic Disorder
  • Research And Development
  • Reproductive Health
  • Genetic Testing
  • Cancer
  • World
  • China
  • Cancer Incidence

The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety...

  • Diagnostics
  • Blood Disease
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Surgical Procedures Performed
  • Mortality Rate

The Synthetic Biology Market is expected to register a CAGR of 20.7% during the forecast period. There are certain factors propelling the growth of the market, including increasing support from the government and private institutions, increasing R&D investments in drug discovery, and the development and declining cost of DNA sequencing and...

  • Genomics
  • Research And Development
  • Infectious Disease
  • Healthcare
  • Drug Development
  • APAC
  • United States
  • Europe
  • Biofuel Production
  • Gross Domestic Expenditure On R&D

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

The Middle East and Africa molecular quality controls market is expected to reach US$ 12.52 million by 2028 from US$ 6.87 million in 2021; it is estimated to grow at a CAGR of 9.0% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • In Vitro Diagnostics
  • Genetic Testing
  • Drug Development
  • Middle East
  • Africa
  • Health Expenditure
  • Direct Sales

The Global Carrier Screening Market size is expected to reach $2,501.94 million by 2027, rising at a market growth of 10.81% CAGR during the forecast period. Carrier screening refers to a type of testing procedure that allows an end-user to know if he/she has a gene for any kind of genetic disorder. Carrier screening is broadly implemented...

  • Healthcare
  • Molecular Diagnostics
  • Infectious Disease
  • World
  • United States
  • Health Provider Density

The North America molecular quality controls market is expected to reach US$ 155.61 million by 2028 from US$ 75.79 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • North America
  • United States
  • Cancer Incidence
  • Direct Sales

The South and Central America molecular quality controls market is expected to reach US$ 22.84 million in 2028 from US$ 11.94 million in 2021; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases...

  • Molecular Diagnostics
  • Infectious Disease
  • Laboratory
  • Genetic Testing
  • Drug Development
  • Central America
  • Chronic Disease Prevalence
  • Diabetes Prevalence

The Asia Pacific molecular quality controls market is expected to reach US$ 72.07 million in 2028 from US$ 34.27 million in 2021; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028. Factors such as burgeoning demand for personalized medicines, declining cost of sequencing procedures, and increasing prevalence of genetic diseases...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • APAC
  • Direct Sales
  • Chronic Disease Prevalence

The Europe molecular quality controls market is expected to reach US$ 109.59 million by 2028 from US$ 55.76 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth...

  • Infectious Disease
  • Molecular Diagnostics
  • Laboratory
  • Genetic Testing
  • Drug Development
  • Europe
  • Cancer Incidence
  • Medical Technology Density

The Global Molecular Quality Controls Market size is expected to reach $259.4 million by 2028, rising at a market growth of 6.6% CAGR during the forecast period. Molecular quality controls are used to assess the performance of molecular tests like leukocyte reduced apheresis platelet (LRAP) units, virus load assays, pathogen detection,...

  • Diagnostics
  • Infectious Disease
  • Laboratory
  • Molecular Diagnostics
  • In Vitro Diagnostics
  • World
  • United States
  • Europe
  • Drug Approval

The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis...

  • Healthcare
  • Infectious Disease
  • Cancer
  • World
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

Global Sequencing Reagents Market 2022-2026 The analyst has been monitoring the sequencing reagents market and it is poised to grow by $ 4.09 bn during 2022-2026, progressing at a CAGR of 12.32% during the forecast period. Our report on the sequencing reagents market provides a holistic analysis, market size and forecast,...

  • Genetic Disorder
  • Marketing Research
  • Bioinformatics
  • World

Report Scope: This report provides an updated review of pharmacogenomics, including materials, equipment, and strategies, and identifies current and emerging applications for pharmacogenomic products. The analyst delineates the current market status for pharmacogenomics, defines trends, and presents growth forecasts...

  • Cardiovascular Disease
  • Managed Care
  • Dementia
  • Research And Development
  • Psychotic Disorder
  • Genetic Testing
  • World
  • United States

Carrier Screening Market by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices, and Others)- Global Opportunity Analysis and Industry Forecast, 2021-2030 The...

  • Genetic Disorder
  • Molecular Diagnostics
  • World
  • APAC

The global agrigenomics market is estimated to be USD 3.3 billion in 2021 and is projected to reach USD 5.3 billion by 2026, at a CAGR of 9.7% from 2021 to 2026. The agrigenomics market is increasingly driven by technological advancements in systems & services of applied genomics, demonstrable increase in the efficiency and productivity of...

  • Genomics
  • Infectious Disease
  • World
  • North America
  • APAC
  • Europe
  • Livestock Production
  • Crop Production

The global pharmacogenomics market reached a value of US$ 6.6 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 11.3 Billion by 2027, exhibiting a CAGR of 9.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • HIV AIDS
  • Molecular Diagnostics
  • Genomics
  • Research And Development
  • World

Major players in the clinical oncology next-generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Cancer
  • DNA Sequencing
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

The molecular quality controls market is expected to reach US$ 372.64 million in 2028 from US$ 184.62 million in 2021; it is estimated to grow at a CAGR of 10.6% during 2021–2028. The growth of the market is mainly attributed to the key driving factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing...

  • Infectious Disease
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Central America
  • Cancer Incidence
  • Health Expenditure

The global carrier screening market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Pathology
  • Molecular Diagnostics
  • Genetic Disorder
  • Genomics
  • World

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However,an unfavorable reimbursement scenario is expected...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Health Expenditure
  • Disposable Income

The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the...

  • Healthcare
  • Diagnostics
  • Laboratory
  • Infectious Disease
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Cancer Incidence

PCR is an enzymatic reaction process in which multiple copies of desired DNA sequence is obtained in a short period of time. The technique is broadly accepted in research and clinical diagnostic application due to its high accuracy and sensitivity. The evolution of PCR instruments with different designs such as interchangeable...

  • Molecular Diagnostics
  • Infectious Disease
  • World
  • United States
  • Infectious Disease Incidence
  • Health Expenditure

2022 France Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation...

  • Infectious Disease
  • France

2022 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation...

  • Infectious Disease
  • Germany

2022 Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline This comprehensive...

  • Infectious Disease
  • Italy

2022 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline This...

  • Infectious Disease
  • Japan

2022 Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline This...

  • Infectious Disease
  • Spain

2022 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation...

  • Infectious Disease
  • United Kingdom

2022 US Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026, Latest Technologies and Instrumentation Pipeline This...

  • Infectious Disease
  • United States